MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Stock-based compensation
Accounts payable
Inventory write-down
Others
Negative Cash Flow Breakdown
Capitalized software
Repayments of financed insurance...
Accrued liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-07-31
2026-04-30
2026-01-31
2025-10-31
Net loss
-3,172,344
-2,750,904
-1,985,208
-2,350,769
Depreciation
6,332
6,758
6,916
7,006
Amortization of debt discounts and deferred financing costs
100,833
100,833
21,287
263,880
Amortization - right-of-use assets, operating lease
28,196
27,244
26,322
25,429
Impairment of deferred offering costs
-
748,599
-
-
Stock-based compensation
738,889
324,841
376,100
436,884
Warrants issued to non-employees
-
0
78,761
29,574
Inventory write-down
251,880
-
-
-
Accounts receivable
0
0
0
0
Inventory
-760
-1,656
0
7,778
Prepaid and other current assets
-67,790
-98,875
-257,303
20,569
Deferred offering costs
-21,900
73,455
116,707
414,574
Capitalized software
-
258,068
258,420
198,703
Accounts payable
704,440
-92,400
93,337
34,165
Accrued liabilities
-34,578
220,790
68,179
-334,208
Other current liabilities
-
0
-
-
Lease liability, operating lease
-32,957
-31,317
-30,396
-29,503
Net cash used in operating activities
-1,318,859
-1,676,548
-1,462,526
-2,334,266
Purchase of property and equipment
-
0
-9,476
13,030
Acquisition of intellectual property - intangibles
5,609
0
37,344
2,740
Capitalized software
274,498
-
-
-
Net cash used in investing activities
-280,107
0
-27,868
-15,770
Issuance of series d preferred stock and warrants, net of issuance costs
0
0
5,549,207
-
Proceeds from shareholder note, net
-
0
-
-
Issuance of series d prefered stock and warrants, net of issuance costs
-
-
-
1,752,831
Issuance of common stock, net of fees
10,233
0
172,839
-
Proceeds from 2.5m streeterville note, net-Streeterville Note One
-
0
-
-
Issuance of common stock, net of fees
-
-
-
172,839
Principal repayments on the 2.5m streeterville note
-
-
450,000
-
Proceeds from 2.5m streeterville note, net-Streeterville Note Two
-
3,000,000
-
-
Principal repayments on the streeterville note
-
-
-
350,000
Proceeds from 3.6m streeterville note, net
-
-
3,000,000
-
Principal repayments on the 2.5m streeterville note
0
450,000
-
-
Repayments of financed insurance premiums
38,175
63,673
63,674
114,824
Net cash (used in) provided by financing activities
-27,942
-63,673
2,936,326
1,508,908
Net change in cash and cash equivalents during the period
-1,626,908
-1,740,221
1,445,932
-841,128
Cash and cash equivalents at beginning of period
-
-
-
1,098,098
Cash and cash equivalents, beginning of period
1,656,814
3,397,035
1,098,098
-
Cash and cash equivalents at end of period
-
-
-
1,951,103
Cash and cash equivalents, end of period
29,906
1,656,814
3,397,035
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
HSCSW Cash Flow Sankey Diagram
Sankey diagram visualizing HSCSW cash flow for the period
Net change in cash
and cash...
-$1,626,908
(-196.03%↓ Y/Y)
Stock-based compensation
$738,889
(323.29%↑ Y/Y)
Accounts payable
$704,440
(2087.92%↑ Y/Y)
Inventory write-down
$251,880
Amortization of debt
discounts and deferred...
$100,833
(-8.29%↓ Y/Y)
Prepaid and other
current assets
-$67,790
(-169.35%↓ Y/Y)
Amortization - right-of-use
assets, operating lease
$28,196
(14.79%↑ Y/Y)
Deferred offering costs
-$21,900
(-109.74%↓ Y/Y)
Depreciation
$6,332
(-10.95%↓ Y/Y)
Inventory
-$760
(0.00%↑ Y/Y)
Issuance of common stock,
net of fees
$10,233
Net cash used in
operating activities
-$1,318,859
(32.48%↑ Y/Y)
Net cash used in
investing activities
-$280,107
(-34311.18%↓ Y/Y)
Net cash (used in)
provided by financing...
-$27,942
(-100.77%↓ Y/Y)
Canceled cashflow
$1,921,020
Canceled cashflow
$10,233
Net loss
-$3,172,344
(-54.37%↓ Y/Y)
Capitalized software
$274,498
Acquisition of intellectual
property - intangibles
$5,609
(589.07%↑ Y/Y)
Repayments of financed
insurance premiums
$38,175
(-20.57%↓ Y/Y)
Accrued liabilities
-$34,578
(-120.74%↓ Y/Y)
Lease liability,
operating lease
-$32,957
(-16.45%↓ Y/Y)
Buy us a coffee
HeartSciences Inc. (HSCSW)
HeartSciences Inc. (HSCSW)